Kristine Torjesen, MD, MPHAssociate Director, Science Facilitation and Project Director, OPTIONS Consortium
Areas of expertise
- Reproductive health
- Quality improvement
- Implementation science
- Clinical trials
- Health systems strengthening
- Maternal neonatal child health
Projects & Resources
The OPTIONS Consortium represents an international, multidisciplinary partnership of global, regional and country experts across the antiretroviral-based HIV prevention research-to-rollout continuum. The consortium’s goal is to provide targeted support to expedite and sustain access to ARV-based HIV prevention products in countries and among populations where most needed.
FHI 360 works with partners in Africa, Asia, Latin America and the United States to assess the safety, acceptability and effectiveness of potential microbicides in preventing HIV and other sexually transmitted infections.
This fact sheet presents an overview of the OPTIONS Consortium, which provides targeted support to help expedite and sustain access to new antiretroviral-based HIV prevention products in countries and among populations where most needed.